Assignee
CYTOKINE PHARMASCIENCES INC
US·16 granted patents·9 pending applications·92 citations·filing 1996–2009
Top patents by PatentIndex Score
25 records- 0189US6673777B1Guanylhydrazones useful for treating diseases associated with T cell activationCYTOKINE PHARMASCIENCES INC·Filed 2000·Granted Jan 6, 2004·36 cites·3 claims
- 0287US7517523B2Anti-MIF antibodiesCYTOKINE PHARMASCIENCES INC·Filed 2003·Granted Apr 14, 2009·8 cites·17 claims
- 0382US7928130B2Isoxazoline compounds having MIF antagonist activityCYTOKINE PHARMASCIENCES INC·Filed 2009·Granted Apr 19, 2011·4 cites·5 claims
- 0480US7244765B2Guanylhydrazone salts, compositions, processes of making and methods of usingCYTOKINE PHARMASCIENCES INC·Filed 2005·Granted Jul 17, 2007·4 cites·9 claims
- 0576US7741057B2Method for screening for compounds using MHC class II invariant chain polypeptide and macrophage migration inhibitory factorCYTOKINE PHARMASCIENCES INC·Filed 2007·Granted Jun 22, 2010·1 cites·4 claims
- 0675US7863334B2Guanylhydrazone compounds, compositions, methods of making and usingCYTOKINE PHARMASCIENCES INC·Filed 2007·Granted Jan 4, 2011·2 cites·20 claims
- 0775US6774227B1Therapeutic uses of factors which inhibit or neutralize MIF activityCYTOKINE PHARMASCIENCES INC·Filed 1996·Granted Aug 10, 2004·19 cites·1 claims
- 0873US2010137566A1Compounds and Methods Used to Treat Infectious DiseasesCYTOKINE PHARMASCIENCES INC·Filed 2008·Application pending·0 cites
- 0972US7662843B2Isoxazoline compounds having MIF antagonist activityCYTOKINE PHARMASCIENCES INC·Filed 2004·Granted Feb 16, 2010·4 cites·5 claims
- 1072US2010184091A1Method for determining MIF contentCYTOKINE PHARMASCIENCES INC·Filed 2009·Application pending·0 cites
- 1170US7491740B2Isoxazoline compounds having MIF antagonist activityCYTOKINE PHARMASCIENCES INC·Filed 2002·Granted Feb 17, 2009·3 cites·6 claims
- 1269US6998238B2Method for determining MIF contentCYTOKINE PHARMASCIENCES INC·Filed 2000·Granted Feb 14, 2006·5 cites·10 claims
- 1365US7741372B2Guanylhydrazones useful for treating diseases associated with T cell activationCYTOKINE PHARMASCIENCES INC·Filed 2003·Granted Jun 22, 2010·2 cites·20 claims
- 1463US2011245156A1Novel antiviral compounds, compositions, and methods of useCYTOKINE PHARMASCIENCES INC·Filed 2009·Application pending·0 cites
- 1562US7205107B2Macrophage migration inhibitory factor (MIF) promoter polymorphism in inflammatory diseaseCYTOKINE PHARMASCIENCES INC·Filed 2002·Granted Apr 17, 2007·3 cites·3 claims
- 1659US2009036540A1Guanylhydrazones in Methods of Treatment or Diagnosis as Modulators of Signal TransductionCYTOKINE PHARMASCIENCES INC·Filed 2008·Application pending·0 cites
- 1755US2008113997A1Compounds, compositions, processes of making, and methods of use related to inhibiting macrophage migration inhibitory factorCYTOKINE PHARMASCIENCES INC·Filed 2007·Application pending·0 cites
- 1854US7291647B2Guanylhydrazone compounds, compositions, methods of making and usingCYTOKINE PHARMASCIENCES INC·Filed 2005·Granted Nov 6, 2007·0 cites·20 claims
- 1951US2010179225A1POI PreventionCYTOKINE PHARMASCIENCES INC·Filed 2009·Application pending·0 cites
- 2050US7795314B2Protective role of semapimod in necrotizing enterocolitisCYTOKINE PHARMASCIENCES INC·Filed 2006·Granted Sep 14, 2010·0 cites·9 claims
- 2149US2011237679A1Novel antiviral compounds, compositions, and methods of useCYTOKINE PHARMASCIENCES INC·Filed 2009·Application pending·0 cites
- 2249US2006264475A1Compounds, compositions and methods for inhibiting or treating hiv-1CYTOKINE PHARMASCIENCES INC·Filed 2006·Application pending·0 cites
- 2346US6906076B2Compounds and methods of use to treat infectious diseasesCYTOKINE PHARMASCIENCES INC·Filed 2003·Granted Jun 14, 2005·1 cites·31 claims
- 2444US8034840B2Guanylhydrazone salts, compositions, processes of making, and methods of usingCYTOKINE PHARMASCIENCES INC·Filed 2007·Granted Oct 11, 2011·0 cites·12 claims
- 2540US2008096909A1Apomorphine inhibitors of amyloid-beta (abeta) fibril formation and their use in amyloidosis based diseaseCYTOKINE PHARMASCIENCES INC·Filed 2007·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →